Cieplinska Agnieszka 4
4 · MOMENTA PHARMACEUTICALS INC · Filed Apr 14, 2020
Insider Transaction Report
Form 4
Cieplinska Agnieszka
Chief Accounting Officer (PAO)
Transactions
- Award
Common Stock
2020-04-12+3,150→ 4,082 total - Sale
Common Stock
2020-04-14$29.57/sh−921$27,234→ 3,161 total - Award
Restricted Stock Units
2020-04-12+3,150→ 3,150 total→ Common Stock (3,150 underlying)
Footnotes (5)
- [F1]Shares received pursuant to settlement of Performance Stock Units that were granted on April 12,2019.
- [F2]Includes 932 shares acquired under the issuer's employee stock purchase plan at a price of $9.76 per share on January 31, 2020.
- [F3]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F4]Each Restricted Stock Unit represents a contingent right to receive one share of MNTA common stock.
- [F5]Subject to the officer's continued employment with the company, the Restricted Stock Units will vest on March 5, 2021.